These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
134 related items for PubMed ID: 8065646
1. Ketorolac: a new antiinflammatory for seasonal allergic conjunctivitis. Holdcroft C. Nurse Pract; 1994 May; 19(5):30. PubMed ID: 8065646 [No Abstract] [Full Text] [Related]
2. Ketorolac for seasonal allergic conjunctivitis. Med Lett Drugs Ther; 1993 Sep 17; 35(905):88-9. PubMed ID: 8361452 [No Abstract] [Full Text] [Related]
3. Topical ketorolac 0.5% solution for the treatment of vernal keratoconjunctivitis. Sharma A, Gupta R, Ram J, Gupta A. Indian J Ophthalmol; 1997 Sep 17; 45(3):177-80. PubMed ID: 9475021 [Abstract] [Full Text] [Related]
4. Clinical evaluation of ketorolac tromethamine 0.5% ophthalmic solution for the treatment of seasonal allergic conjunctivitis. Ballas Z, Blumenthal M, Tinkelman DG, Kriz R, Rupp G. Surv Ophthalmol; 1993 Sep 17; 38 Suppl():141-8. PubMed ID: 8236005 [Abstract] [Full Text] [Related]
5. Double-masked, paired-comparison clinical study of ketorolac tromethamine 0.5% ophthalmic solution compared with placebo eyedrops in the treatment of seasonal allergic conjunctivitis. Tinkelman DG, Rupp G, Kaufman H, Pugely J, Schultz N. Surv Ophthalmol; 1993 Sep 17; 38 Suppl():133-40. PubMed ID: 8236004 [Abstract] [Full Text] [Related]
6. Nonsteroidal eye drops for ocular allergy. Schwab IR. West J Med; 1994 Dec 17; 161(6):594-5. PubMed ID: 7856163 [No Abstract] [Full Text] [Related]
7. A multicenter comparison of the ocular efficacy and safety of diclofenac 0.1% solution with that of ketorolac 0.5% solution in patients with acute seasonal allergic conjunctivitis. Tauber J, Raizman MB, Ostrov CS, Laibovitz RA, Abelson MB, Betts JG, Koester JM, Gill D, Schaich L. J Ocul Pharmacol Ther; 1998 Apr 17; 14(2):137-45. PubMed ID: 9572539 [Abstract] [Full Text] [Related]
8. [Upper digestive hemorrhage after oral administration of ketorolac]. Marcos Sánchez F, Aparicio Martínez JC, Arranz Nieto MJ, Pérez-Navarro AD. An Med Interna; 1994 Oct 17; 11(10):513-4. PubMed ID: 7865663 [No Abstract] [Full Text] [Related]
11. Ketorolac-induced acute renal failure in a previously healthy adolescent. Buck ML, Norwood VF. Pediatrics; 1996 Aug 17; 98(2 Pt 1):294-6. PubMed ID: 8692635 [No Abstract] [Full Text] [Related]
12. Comparative effects of ketorolac 0.5% or diclofenac 0.1% ophthalmic solutions on inflammation after cataract surgery. Flach AJ, Dolan BJ, Donahue ME, Faktorovich EG, Gonzalez GA. Ophthalmology; 1998 Sep 17; 105(9):1775-9. PubMed ID: 9754191 [Abstract] [Full Text] [Related]
13. [Ketorolac tromethamine--with special reference to postoperative pain therapy]. Andersen SS, Jensen ME. Ugeskr Laeger; 1994 Feb 21; 156(8):1160-3. PubMed ID: 8116102 [No Abstract] [Full Text] [Related]
14. Corneal sensitivity debate. Villain M, Trinquand C, Arnaud B. Arch Ophthalmol; 1997 May 21; 115(5):686. PubMed ID: 9152147 [No Abstract] [Full Text] [Related]
15. Ketorolac, nasal polyposis, and bronchial asthma: a cause for concern. Haddow GR, Riley E, Isaacs R, McSharry R. Anesth Analg; 1993 Feb 21; 76(2):420-2. PubMed ID: 8424525 [No Abstract] [Full Text] [Related]